The medical industry is seeing a major shift in glucose care with the arrival of GLP-1 transdermal devices. These groundbreaking methods offer a likely convenient option to subcutaneous injections for individuals managing diabetes. By circumventing the necessity for frequent injections, GLP-1 adhesives promise to boost patient compliance and overal